Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Pesce

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|October 11, 2016
RNF5, DAB2 and Friends: Novel Drug Targets for Cystic FibrosisElvira Sondo, Emanuela Pesce, Valeria Tomati, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosisEmanuela Pesce, Nicoletta Pedemonte, Alberto Leoni, et al.
Frontiers in Immunology|May 23, 2019
High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET FormationElvira Sondo, Roberta Bertelli, Emanuela Pesce, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 17, 2017
Therapeutic approaches to CFTR dysfunction: From discovery to drug developmentHongyu Li, Emanuela Pesce, David N Sheppard, et al.
The Journal of Physiology|March 6, 2025
The apical mucus layer alters the pharmacological properties of the airway epitheliumDaniela Guidone, Martina de Santis, Emanuela Pesce, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 7, 2020
Synthesis and Structure-activity Relationship of Aminoarylthiazole Derivatives as Potential Potentiators of the Chloride Transport Defect in Cystic FibrosisNara Liessi, Emanuela Pesce, Annalisa Salis, et al.
JCI Insight|July 17, 2020
Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including TrikaftaNara Liessi, Emanuela Pesce, Clarissa Braccia, et al.
Chemmedchem|December 17, 2023
Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del-CFTRAndrea Spallarossa, Nicoletta Pedemonte, Emanuela Pesce, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR ModulatorsRoberto Sabbadini, Emanuela Pesce, Alice Parodi, et al.
Applied Spectroscopy|September 6, 2022
Changing the Microstructural and Chemical Properties of Graphene Oxide Through a Chemical RouteMaria Lucia Protopapa, Emiliano Burresi, Martino Plamisano, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|October 11, 2016
RNF5, DAB2 and Friends: Novel Drug Targets for Cystic FibrosisElvira Sondo, Emanuela Pesce, Valeria Tomati, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosisEmanuela Pesce, Nicoletta Pedemonte, Alberto Leoni, et al.
Frontiers in Immunology|May 23, 2019
High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET FormationElvira Sondo, Roberta Bertelli, Emanuela Pesce, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 17, 2017
Therapeutic approaches to CFTR dysfunction: From discovery to drug developmentHongyu Li, Emanuela Pesce, David N Sheppard, et al.
The Journal of Physiology|March 6, 2025
The apical mucus layer alters the pharmacological properties of the airway epitheliumDaniela Guidone, Martina de Santis, Emanuela Pesce, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 7, 2020
Synthesis and Structure-activity Relationship of Aminoarylthiazole Derivatives as Potential Potentiators of the Chloride Transport Defect in Cystic FibrosisNara Liessi, Emanuela Pesce, Annalisa Salis, et al.
JCI Insight|July 17, 2020
Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including TrikaftaNara Liessi, Emanuela Pesce, Clarissa Braccia, et al.
Chemmedchem|December 17, 2023
Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del-CFTRAndrea Spallarossa, Nicoletta Pedemonte, Emanuela Pesce, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR ModulatorsRoberto Sabbadini, Emanuela Pesce, Alice Parodi, et al.
Applied Spectroscopy|September 6, 2022
Changing the Microstructural and Chemical Properties of Graphene Oxide Through a Chemical RouteMaria Lucia Protopapa, Emiliano Burresi, Martino Plamisano, et al.
Pageof 5